Literature DB >> 23784757

Symptomatic hypocalcaemia secondary to PTH resistance associated with hypomagnesaemia after elective embolisation of uterine fibroid.

Tomas Patrick Griffin1, Michael Murphy, John Coulter, Matthew Stjohn Murphy.   

Abstract

Four weeks after elective embolisation of a symptomatic benign uterine fibroid, a lady presented to her general practitioner with facial twitching and severe lassitude. Acute hypocalcaemia was diagnosed. Further investigations demonstrated hypomagnesaemia. Parathyroid hormone (PTH) was within normal limits. Symptoms and the acute metabolic disturbance resolved with treatment by oral magnesium and calcium supplementation. While lassitude is a common symptom of postfibroid embolisation and may last for up to 6 weeks, the presentation with facial twitching alerted the clinician to a potential electrolyte or metabolic imbalance. This is a first reported case of hypomagnesaemia associated with PTH resistance leading to hypocalcaemia precipitated by alcohol particle embolisation for benign fibroid disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784757      PMCID: PMC3702835          DOI: 10.1136/bcr-2013-008708

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Metabolic complications associated with use of thiazide diuretics.

Authors:  Biff F Palmer; Amir Said Alizadeh Naderi
Journal:  J Am Soc Hypertens       Date:  2007 Nov-Dec

Review 2.  Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels.

Authors:  R A Reinhart
Journal:  Arch Intern Med       Date:  1988-11

3.  Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver.

Authors:  G M Mavligit; R E Pollock; H L Evans; S Wallace
Journal:  Cancer       Date:  1993-07-15       Impact factor: 6.860

4.  Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.

Authors:  R K Rude; S B Oldham; F R Singer
Journal:  Clin Endocrinol (Oxf)       Date:  1976-05       Impact factor: 3.478

5.  Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.

Authors:  Takao Tamura; Toshiyuki Sakaeda; Kaori Kadoyama; Yasushi Okuno
Journal:  Int J Med Sci       Date:  2012-06-13       Impact factor: 3.738

  5 in total
  4 in total

1.  Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study.

Authors:  Tonya S Orchard; Joseph C Larson; Nora Alghothani; Sharon Bout-Tabaku; Jane A Cauley; Zhao Chen; Andrea Z LaCroix; Jean Wactawski-Wende; Rebecca D Jackson
Journal:  Am J Clin Nutr       Date:  2014-02-05       Impact factor: 7.045

2.  Low serum magnesium levels are associated with increased risk of fractures: a long-term prospective cohort study.

Authors:  Setor Kwadzo Kunutsor; Michael Richard Whitehouse; Ashley William Blom; Jari Antero Laukkanen
Journal:  Eur J Epidemiol       Date:  2017-04-12       Impact factor: 8.082

3.  Magnesemia: an independent risk factor of hypocalcemia after thyroidectomy.

Authors:  Wenlong Wang; Chaoyang Meng; Qianhui Ouyang; Jing Xie; Xinying Li
Journal:  Cancer Manag Res       Date:  2019-09-03       Impact factor: 3.989

Review 4.  Hypomagnesemia in critically ill patients.

Authors:  Bent-Are Hansen; Øyvind Bruserud
Journal:  J Intensive Care       Date:  2018-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.